SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity - Test2 - elhamkhani - TriplyDB

SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity

SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity

http://www.wikidata.org/entity/Q28295413

about

Allosteric Modulation of Sigma-1 Receptors Elicits Rapid Antidepressant Activity Effects of SKF83959 on the excitability of hippocampal CA1 pyramidal neurons: a modeling study.Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.SKF83959 produces antidepressant effects in a chronic social defeat stress model of depression through BDNF-TrkB pathway.Allosteric modulation of sigma-1 receptors elicits anti-seizure activities Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics.Allosteric modulation of sigma-1 receptors by SKF83959 inhibits microglia-mediated inflammation.Dihydromyricetin exerts a rapid antidepressant-like effect in association with enhancement of BDNF expression and inhibition of neuroinflammation.

P2860

Q28273055-A408F3E9-3C08-4194-9AAB-1EBD39C4D3F2 Q33861896-79251CDF-19A2-43B1-96A1-FB199C32F508 Q34461713-BFC28EAE-BB27-4AF8-9857-07C2C5C418CD Q35626923-8385D7E6-4832-4691-A2E4-B2CF07C88621 Q35978091-4620EF0A-5713-41B2-B8C7-A709E40C4298 Q37158450-0A7BFFC7-65A5-4727-A686-70C3B98CFE79 Q38736252-1C2EC966-7A9A-4761-98AD-2F55A41B47C9 Q38868897-A335E731-8E23-4DA9-B1BD-99787996D0FB Q47731890-5065ACCC-9C74-423C-A555-EE1F5AB68BD7

P2860

SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity

http://www.wikidata.org/entity/Q28295413

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity

@ast

SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity

@en

SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity

@nl

type

label

SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity

@ast

SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity

@en

SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity

@nl

prefLabel

SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity

@ast

SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity

@en

SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity

@nl

P1433

Q28295413-49CD919E-8B8A-4716-B0A9-0CD8E47207B4

P1476

Q28295413-A851994D-A218-4398-B830-D63814ABF0F8

P2093

Q28295413-07CCEAF4-8968-4557-93AD-9F0B1DE799FA

Q28295413-2F3197F2-3FF3-4AB5-B619-CE99C9FCD869

Q28295413-7033B927-A677-413B-B1BB-8AC458046FC3

Q28295413-755A08A9-B95F-420D-A5AD-DAF090B384B1

Q28295413-7B55520C-4B55-4A5A-970C-9554B66AAC18

Q28295413-80B6B630-1107-4E80-993D-C30429A7D5F9

Q28295413-ADF4D441-40A2-4A13-B4D4-C8D92F159AA3

Q28295413-AF8DA130-B95B-47DC-A287-ADE4F2B6FF49

Q28295413-E1369830-22AD-499D-8423-9E61B05B67A6

P2860

Q28295413-044DAE76-F89C-4B3A-B402-0003200488C4

Q28295413-0A2C874A-E430-443C-ADB2-356650E30A6B

Q28295413-1AD44A72-A33A-48C1-AEED-8B24511E8ECA

Q28295413-296C08BD-05E6-47B5-871B-67BA79837BDF

Q28295413-326B10BB-2D88-45B6-B583-B6E2FDF37B61

Q28295413-3ECAA1F5-2878-4D33-B1C1-58DA66C5D657

Q28295413-476882DA-3DB5-4BA4-A3A0-C086D640F049

Q28295413-48BB2B65-7D30-402E-BDAD-DBE6D14F2D85

Q28295413-6C0AC7BD-7E30-4DDE-A719-126C94C0340C

Q28295413-71F81526-2F23-4D29-BDAF-2DADE2491E57

P2888

Q28295413-D881E007-490F-4E1C-BEF6-3BDE7E25573A

P304

Q28295413-FB33499D-D77D-4426-A473-E529AB300508

P31

Q28295413-815D0068-D9FF-45CF-AD3E-B6DA1351A35A

P356

Q28295413-6A78BEA0-B07E-4BFB-91FD-2DCFE2561A6D

P407

Q28295413-AA46E661-D2A1-4B82-8B1A-7B1DBC114391

P433

Q28295413-C24D93CC-B8B6-4CC0-AAE9-EEB06234A77E

P478

Q28295413-00F4D87F-7F3F-40FF-B258-F3C5A03ADF4C

P577

Q28295413-9505E381-3DC6-4246-A018-E4D4E33D97CA

P5875

Q28295413-50AE9778-5E55-45E2-8623-232E608E2453

P6179

Q28295413-699411FF-272B-4E46-91BA-158DE97D1B86

P698

Q28295413-4C120507-67C0-4F39-ACAA-36BDB31F403B

P932

Q28295413-ADFF389A-0EEB-4A24-A19F-CAA708B39BA3

P356

P1433

Acta Pharmacologica Sinica

P1476

SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity

@en

P2093

Ao Zhang

http://www.w3.org/2001/XMLSchema#string

Bin Zhao

http://www.w3.org/2001/XMLSchema#string

Guo-zhang Jin

http://www.w3.org/2001/XMLSchema#string

Jia Jia

http://www.w3.org/2001/XMLSchema#string

Jian-qi Li

http://www.w3.org/2001/XMLSchema#string

Lin Guo

http://www.w3.org/2001/XMLSchema#string

Xing Fang

http://www.w3.org/2001/XMLSchema#string

Xue-chu Zhen

http://www.w3.org/2001/XMLSchema#string

Yong-yong Zheng

http://www.w3.org/2001/XMLSchema#string

P2860

Arylbenzazepines are potent modulators for the delayed rectifier K+ channel: a potential mechanism for their neuroprotective effects

Neurotransmitter transporters: fruitful targets for CNS drug discovery

Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor

Triple uptake inhibitors: therapeutic potential in depression and beyond

Current investigational drugs for major depression

Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial

Depression: a new animal model sensitive to antidepressant treatments

Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors

In-vitro and in-vivo characterization of JNJ-7925476, a novel triple monoamine uptake inhibitor

Antidepressant-like pharmacological profile of a novel triple reuptake inhibitor, (1S,2S)-3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol (PRC200-SS)

P2888

P304

1149-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/APS.2013.66

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

253334525

http://www.w3.org/2001/XMLSchema#string

P6179

1000395500

http://www.w3.org/2001/XMLSchema#string

P698

23892272

http://www.w3.org/2001/XMLSchema#string

P932

4003162

http://www.w3.org/2001/XMLSchema#string